Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000303
Chunk: 109

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 109
---
 and delivered by the Company and
(iv) this Note, and each other Transaction Document upon its execution on behalf of the Company, shall constitute, the valid and binding
obligations of the Company enforceable against the Company in accordance with their terms, except as such enforceability may be limited
by general principles of equity or applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or other laws relating to,
or affecting generally, the enforcement of creditors’ rights and remedies. The Board of Directors has approved the resolutions (the
“”) substantially in the form provided to the Holder to authorize this Note and the transactions
contemplated hereby. The Signing Resolutions are valid, in full force and effect and have not been modified or supplemented in any respect.
The Company has delivered to the Holder a true and correct copy of minutes of a meeting of the Board of Directors at which the Signing
Resolutions were duly adopted by the Board of Directors or a unanimous written consent adopting the Signing Resolutions executed by all
of the members of the Board of Directors. No other approvals or consents of the Board of Directors, any authorized committee thereof,
or shareholder is necessary under applicable laws and the Company’s Articles of Association to authorize the execution and delivery
of this Note.

(c) . The execution, delivery and performance of this Note by the Company and the consummation by the Company of the transactions
contemplated hereby will not (i) result in a violation of the Company’s Articles of Association or (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is
a party, or result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws
and regulations, the rules of the Principal Market applicable to the Company or any of its Subsidiaries) or by which any property or asset
of the Company or any of its Subsidiaries is bound or affected, except in the case of conflicts, defaults, terminations, amendments, accelerations,
cancellations and violations under clause (ii), which would not reasonably be expected to result in a Material Adverse Effect. Neither
the Company nor its Subsidiaries is in violation of any term of or in default